Marcus Brans, a member of the Digitization Group and head of communications at Triton Partners, discusses the most important way that investors can add value to companies at the DACH Private Equity Forum.
Backers close a $18.6m round started in 2015 with an initial $10.6m capital injection
GP invests via its Nordic Capital Fund IX, which held a final close on €4.3bn in May 2018
Abalos Therapeutics is a biotechnology company focused on developing immuno-oncology therapeutics
Existing management team will lead the company's future growth and development